You just read:

The Zacks Analyst Blog Highlights: WellPoint, AMERIGROUP, Bristol-Myers Squibb, Amylin Pharmaceuticals and Eli Lilly

News provided by

Zacks Investment Research, Inc.

Jul 12, 2012, 09:30 ET